IFN consensus sequence binding protein/IFN regulatory factor-8 guides bone marrow progenitor cells toward the macrophage lineage

被引:78
作者
Tsujimura, H [1 ]
Nagamura-Inoue, T [1 ]
Tamura, T [1 ]
Ozato, K [1 ]
机构
[1] NICHHD, Lab Mol Growth Regulat, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.4049/jimmunol.169.3.1261
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
IFN consensus sequence binding protein (ICSBP; IFN regulatory factor-8) is a transcription factor of the IFN regulatory factor family. Disruption of this gene results in a leukemia-like disease in mice. To investigate the role of ICSBP in myeloid cell development, lineage marker-negative (Lin(-)) bone marrow progenitor cells were purified from ICSBP+/+ and ICSBP-/- mice and tested for gene expression and colony-forming ability. ICSBP was expressed in Lin- progenitor cells, and its levels were markedly increased by IFN-gamma. The colony-forming potential of ICSBP-/- progenitor cells was grossly abnormal, as they gave rise to a disproportionately high number of granulocyte colonies and many fewer macrophage colonies. IFN-gamma inhibited colony formation, while promoting macrophage maturation in ICSBP+/+ cells. In contrast, the effects of IFN-gamma were completely absent in ICSBP-/- progenitors. By retrovirus transduction we tested whether reintroduction of ICSBP restores a normal colony-forming potential in -/- progenitor cells. The wild-type ICSBP, but not transcriptionally defective mutants, corrected abnormal colony formation by increasing macrophage colonies and decreasing granulocyte colonies. Taken together, ICSBP plays a critical role in myeloid cell development by controlling lineage selection and is indispensable for IFN-gamma-dependent modulation of progenitor cell maturation.
引用
收藏
页码:1261 / 1269
页数:9
相关论文
共 47 条
[31]  
RALPH P, 1983, BLOOD, V62, P1169
[32]   Interferon consensus sequence binding protein-deficient mice display impaired resistance to intracellular infection due to a primary defect in interleukin 12 p40 induction [J].
SchartonKersten, T ;
Contursi, C ;
Masumi, A ;
Sher, A ;
Ozato, K .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (09) :1523-1534
[33]   Altered development and cytokine responses of myeloid progenitors in the absence of transcription factor, interferon consensus sequence binding protein [J].
Scheller, M ;
Foerster, J ;
Heyworth, CM ;
Waring, JF ;
Löhler, J ;
Gilmore, GL ;
Shadduck, RK ;
Dexter, TM ;
Horak, I .
BLOOD, 1999, 94 (11) :3764-3771
[34]   Lack of interferon consensus sequence binding protein (ICSBP) transcripts in human myeloid leukemias [J].
Schmidt, M ;
Nagel, S ;
Proba, J ;
Thiede, C ;
Ritter, M ;
Waring, JF ;
Rosenbauer, F ;
Huhn, D ;
Wittig, B ;
Horak, I ;
Neubauer, A .
BLOOD, 1998, 91 (01) :22-29
[35]   Expression of nuclear transcription factor interferon consensus sequence binding protein in chronic myeloid leukemia correlates with pretreatment risk features and cytogenetic response to interferon-α [J].
Schmidt, M ;
Hochhaus, A ;
Nitsche, A ;
Hehlmann, R ;
Neubauer, A .
BLOOD, 2001, 97 (11) :3648-3650
[36]   PU.1 functions in a cell-autonomous manner to control the differentiation of multipotential lymphoid-myeloid progenitors [J].
Scott, EW ;
Fisher, RC ;
Olson, MC ;
Kehrli, EW ;
Simon, MC ;
Singh, H .
IMMUNITY, 1997, 6 (04) :437-447
[37]   Interferon-gamma constitutively expressed in the stromal microenvironment of human marrow cultures mediates potent hematopoietic inhibition [J].
Selleri, C ;
Maciejewski, JP ;
Sato, T ;
Young, NS .
BLOOD, 1996, 87 (10) :4149-4157
[38]  
SHIH JP, 1992, LEUKEMIA, V6, P193
[39]  
SHIOHARA M, 1993, BLOOD, V81, P1435
[40]   PURIFICATION AND CHARACTERIZATION OF MOUSE HEMATOPOIETIC STEM-CELLS [J].
SPANGRUDE, GJ ;
HEIMFELD, S ;
WEISSMAN, IL .
SCIENCE, 1988, 241 (4861) :58-62